Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT07559292
- Status
- Enrolling By Invitation
Conditions
- Diabetes
- Vision Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- AI — OTHERAI-based eye screening program
- Usual Practice — OTHERPCP recommends annual vision screening, a separate visit entirely
Study Details
This pragmatic clinical trial is being conducted to test the effectiveness of AI in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 4 primary care clinics. This is an autonomous AI-based screening to detect diabetic eye disease at primary care visits.
Key Dates
- Start date
- Feb 15, 2026
- Status verified
- Apr 2026
- Primary completion
- Feb 28, 2027
- Completion
- Feb 28, 2027
Study Design
- Enrollment
- 1,700 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Usual CarePatients with diabetes will follow the clinic's usual practice, in which the primary care provider recommends an annual screening eye exam for patients with diabetes. This requires the patient to make a separate visit to see an eye care provider. Clinic staff will provide scheduling assistance per the standard scheduling procedure for the clinic.
- Experimental: AI InterventionAI intervention includes (1) acquisition of eye photos and (2) autonomous (i.e. without human oversight) AI-based identification of referrable or non-referrable eye disease at the primary care clinic.
Primary Outcome Measure
Proportion of patients who get eye screening in the AI and usual-care arms within 5 months of the recommendation [ Time Frame: up to 5 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Wisconsin | Madison | Wisconsin | 53792 | - |
Find similar trials in Madison, WI
By research site
Related Studies
- Enhancing Diabetes Management Approaches for Patients With Uncontrolled DiabetesRecruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A GenePHASE2 · Recruiting · Laboratoires Thea · San Francisco, California
- GLP-1 RA on Liver OMICS in MASLDNot Yet Recruiting · Medical College of Wisconsin · Milwaukee, Wisconsin
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland